首页 正文

Exclusion of Women from Phase I Trials: Perspectives from Investigators and Research Oversight Officials

{{output}}
Over the past 30 years, progress has been made in increasing women's representation in clinical research. However, women continue to be underrepresented in phase I clinical trials-those trials that test the safety and tolerability of investigational drugs, oft... ...